TabsDetailsBasic DetailsDate: Tuesday, August 29, 2017Type: PublicationDescription: Pregnancy registries and spontaneous reports are essential pharmacovigilance tools to evaluate drug safety during pregnancy. The aim of this study was to evaluate postmarket capture of exposed pregnancies. Read More Materials: Drug Safety; August 2017. DOI: 10.1007/s40264-017-0591-5Additional InformationRelated Assessment(s): 2016 ICPE Poster: A Systematic Review of Enrollment and Retention in US Pregnancy Exposure Registries and Corresponding Pharmacovigilance SystemsContributorsAuthor(s): Steven T. Bird PharmD, PhD, MS; Kate Gelperin MD; Lockwood Taylor PhD, MPH; Leyla Sahin MD; Hoda Hammad MS, MPH; Susan E. Andrade ScD; Mohamed A. Mohamoud PharmD, MPH; Sengwee Toh, ScD; Christian Hampp PhDCorresponding Author: S.T. Bird, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD. Email steven.bird@fda.hhs.gov
